Red blood cell aggregation and microcirculation in rat cremaster muscle

Area of Science:

• Physiology
• Microcirculation Research
• Hemodynamics

Background:

• Red blood cell (RBC) aggregation influences blood flow dynamics.
• Understanding the impact of altered RBC aggregation on microvascular function is crucial for tissue oxygenation.

Purpose of the Study:

• To investigate the effects of varying red blood cell aggregation levels on arteriolar velocity and perfused capillary density (PCD).
• To determine the role of high-molecular-weight dextrans and plasma in modulating RBC aggregation and microvascular parameters.

Main Methods:

• Intravital microscopy was used to observe the rat cremaster muscle microcirculation.
• RBC aggregation was modified by infusing dextrans (40,000, 70,000, or 480,000 MW) or rat plasma via normovolemic hemodilution.
• RBC arteriolar velocity and PCD were measured.
• The effect of the antiaggregating drug troxerutin was evaluated.

Main Results:

• High-molecular-weight dextrans (70,000 and 480,000 MW) induced RBC hyperaggregation, decreasing arteriolar velocity by 30-40% and PCD by 35-37%.
• Low-molecular-weight dextran (40,000 MW) and plasma increased RBC arteriolar velocity by 30% without affecting PCD or aggregation.
• Troxerutin significantly inhibited the negative effects of dextran on velocity and PCD.

Conclusions:

• RBC hyperaggregation, induced by high-molecular-weight dextrans, negatively impacts arteriolar velocity and perfused capillary density.
• These changes in microcirculation associated with RBC aggregation may compromise tissue oxygenation.
• Pharmacological intervention with antiaggregating agents can mitigate these adverse effects.